Startup Aims To Tackle High Drug Prices With $200M Series A Financing

Status
Not open for further replies.
Oct 11, 2019
1,223
0
1
The startup, founded by a prominent health policy expert and a biotech industry executive, aims to bring down the cost of drugs by re-engineering and making less costly the process by which they are discovered and brought to patients.

Continue reading...
 
Status
Not open for further replies.